Deutsche Bank’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $646K | Sell |
37,013
-2,090
| -5% | -$36.5K | ﹤0.01% | 2313 |
|
|
2025
Q1 | $492K | Sell |
39,103
-4,274
| -10% | -$53.8K | ﹤0.01% | 2474 |
|
|
2024
Q4 | $458K | Buy |
43,377
+14,604
| +51% | +$154K | ﹤0.01% | 2623 |
|
|
2024
Q3 | $417K | Buy |
28,773
+7,987
| +38% | +$116K | ﹤0.01% | 2526 |
|
|
2024
Q2 | $177K | Buy |
20,786
+6,042
| +41% | +$51.4K | ﹤0.01% | 2836 |
|
|
2024
Q1 | $151K | Sell |
14,744
-508
| -3% | -$5.19K | ﹤0.01% | 2937 |
|
|
2023
Q4 | $83.6K | Buy |
+15,252
| New | +$83.6K | ﹤0.01% | 3253 |
|
|
2022
Q2 | – | Sell |
-11,140
| Closed | -$39K | – | 4117 |
|
|
2022
Q1 | $39K | Sell |
11,140
-1,318
| -11% | -$4.61K | ﹤0.01% | 3819 |
|
|
2021
Q4 | $83K | Buy |
12,458
+658
| +6% | +$4.38K | ﹤0.01% | 3706 |
|
|
2021
Q3 | $118K | Buy |
11,800
+4,058
| +52% | +$40.6K | ﹤0.01% | 3776 |
|
|
2021
Q2 | $239K | Sell |
7,742
-4,588
| -37% | -$142K | ﹤0.01% | 3648 |
|
|
2021
Q1 | $538K | Buy |
12,330
+7,330
| +147% | +$320K | ﹤0.01% | 3036 |
|
|
2020
Q4 | $232K | Buy |
+5,000
| New | +$232K | ﹤0.01% | 3342 |
|